TIDMDPH

RNS Number : 0415A

Dechra Pharmaceuticals PLC

20 September 2022

20 September 2022

Dechra Pharmaceuticals PLC

(the Company)

LEI: 213800J4UVB5OWG8VX82

Notification and public disclosure of transactions by persons discharging managerial responsibilities (PDMRs)

The Company announces that on 20 September 2022 the following Directors were granted awards over Ordinary Shares of 1 pence each in the Company under the Dechra 2021 Deferred Bonus Plan:

 
 Name of individual    Director    Type of award       Number of shares 
                                                        subject to award 
                                   DBP Award - 
 Ian Page              Director     nil cost option          3,580 
                      ----------  ------------------  ------------------ 
                                   DBP Award - 
 Paul Sandland         Director     nil cost option          2,293 
                      ----------  ------------------  ------------------ 
                                   DBP Award - 
                                    conditional 
 Tony Griffin          Director     award                    1,655 
                      ----------  ------------------  ------------------ 
 

In accordance with the Directors' Remuneration Policy, 20% of the annual bonus earned in respect of the Company's 2022 financial year has been deferred into a share award. The awards will vest at the end of a deferral period of two years.

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the Market Abuse Regulation.

Notification of Dealing Form

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                           Ian Page 
     -----------------------------  ------------------------------------ 
 2.   Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                Director 
     -----------------------------  ------------------------------------ 
 b)   Initial notification/          Initial Notification 
       amendment 
     -----------------------------  ------------------------------------ 
 3.   Details of the Issuer 
     ------------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
     -----------------------------  ------------------------------------ 
 b)   LEI code                       213800J4UVB5OWG8VX82 
     -----------------------------  ------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of                 Ordinary Shares of 1 pence each 
       the financial 
       instrument                     ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------  ------------------------------------ 
 b)   Nature of the                  Grant of award over Ordinary Shares 
       transaction                    under the Company's Deferred Bonus 
                                      Plan 
     -----------------------------  ------------------------------------ 
 c)   Price(s) and volumes(s)          Price             Volume 
                                        Nil cost award    3,580 
                                                         ------- 
     -----------------------------  ------------------------------------ 
 d)        Aggregated information 
             *    Aggregate volume 
                                       N/A 
 
             *    Price 
     -----------------------------  ------------------------------------ 
 e)   Date of the transaction        2022-09-20 
     -----------------------------  ------------------------------------ 
 f)   Place of the transaction       Outside a trading venue 
     -----------------------------  ------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                           Paul Sandland 
     -----------------------------  ------------------------------------ 
 2.   Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                Director 
     -----------------------------  ------------------------------------ 
 b)   Initial notification/          Initial Notification 
       amendment 
     -----------------------------  ------------------------------------ 
 3.   Details of the Issuer 
     ------------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
     -----------------------------  ------------------------------------ 
 b)   LEI code                       213800J4UVB5OWG8VX82 
     -----------------------------  ------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of                 Ordinary Shares of 1 pence each 
       the financial 
       instrument                     ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------  ------------------------------------ 
 b)   Nature of the                  Grant of award over Ordinary Shares 
       transaction                    under the Company's Deferred Bonus 
                                      Plan 
     -----------------------------  ------------------------------------ 
 c)   Price(s) and volumes(s)          Price             Volume 
                                        Nil cost award    2,293 
                                                         ------- 
     -----------------------------  ------------------------------------ 
 d)        Aggregated information 
             *    Aggregate volume 
                                       N/A 
 
             *    Price 
     -----------------------------  ------------------------------------ 
 e)   Date of the transaction        2022-09-20 
     -----------------------------  ------------------------------------ 
 f)   Place of the transaction       Outside a trading venue 
     -----------------------------  ------------------------------------ 
 
 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                           Tony Griffin 
     -----------------------------  ------------------------------------ 
 2.   Reason for the notification 
     ------------------------------------------------------------------- 
 a)   Position/status                Director 
     -----------------------------  ------------------------------------ 
 b)   Initial notification/          Initial Notification 
       amendment 
     -----------------------------  ------------------------------------ 
 3.   Details of the Issuer 
     ------------------------------------------------------------------- 
 a)   Name                           Dechra Pharmaceuticals PLC 
     -----------------------------  ------------------------------------ 
 b)   LEI code                       213800J4UVB5OWG8VX82 
     -----------------------------  ------------------------------------ 
 4.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of 
       transaction; (iii) each date; and (iv) each place 
       where transactions have been conducted 
     ------------------------------------------------------------------- 
 a)   Description of                 Ordinary Shares of 1 pence each 
       the financial 
       instrument                     ISIN: GB0009633180 
       Identification 
       code 
     -----------------------------  ------------------------------------ 
 b)   Nature of the                  Grant of award over Ordinary Shares 
       transaction                    under the Company's Deferred Bonus 
                                      Plan 
     -----------------------------  ------------------------------------ 
 c)   Price(s) and volumes(s)          Price             Volume 
                                        Nil cost award    1,655 
                                                         ------- 
     -----------------------------  ------------------------------------ 
 d)        Aggregated information 
             *    Aggregate volume 
                                       N/A 
 
             *    Price 
     -----------------------------  ------------------------------------ 
 e)   Date of the transaction        2022-09-20 
     -----------------------------  ------------------------------------ 
 f)   Place of the transaction       Outside a trading venue 
     -----------------------------  ------------------------------------ 
 

For further information, please contact:

Melanie Hall, Company Secretary

Telephone: 01606 814730

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. For more information please visit: www.dechra.com .

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharm aceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHPPUWCBUPPGAU

(END) Dow Jones Newswires

September 20, 2022 11:44 ET (15:44 GMT)

Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Feb 2024 a Mar 2024 Haga Click aquí para más Gráficas Dechra Pharmaceuticals.
Dechra Pharmaceuticals (LSE:DPH)
Gráfica de Acción Histórica
De Mar 2023 a Mar 2024 Haga Click aquí para más Gráficas Dechra Pharmaceuticals.